Pro Vise Management Group, LLC Viatris Inc Transaction History

Pro Vise Management Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 27, 2022	SELL	$9.81 - $15.4 $122,144 - $191,745	-12,451 Closed	0 $0
Q4 2021 Jan 18, 2022	BUY	$12.09 - $14.68 $11,412 - $13,857	944 Added 8.2%	12,451 $168,000
Q3 2021 Oct 20, 2021	SELL	$13.25 - $15.13 $23,055 - $26,326	-1,740 Reduced 13.14%	11,507 $156,000
Q2 2021 Aug 06, 2021	SELL	$12.97 - $16.15 $151,178 - $188,244	-11,656 Reduced 46.81%	13,247 $189,000
Q1 2021 Apr 22, 2021	SELL	$13.59 - $18.54 $42,346 - $57,770	-3,116 Reduced 11.12%	24,903 $348,000
Q4 2020 Jan 19, 2021	BUY	$14.3 - $18.74 $400,671 - $525,076	28,019 New	28,019 $525,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Pro Vise Management Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Vise Management Group, LLC with notifications on news.